# | Title | Journal | Year | Citations |
---|
1 | Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: A systematic review and meta-analysis | Journal of the American Society of Hypertension | 2014 | 371 |
2 | The insular cortex and cardiovascular system: a new insight into the brain-heart axis | Journal of the American Society of Hypertension | 2010 | 270 |
3 | Particulate matter, air pollution, and blood pressure | Journal of the American Society of Hypertension | 2009 | 250 |
4 | Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial | Journal of the American Society of Hypertension | 2012 | 250 |
5 | Baroreflex Activation Therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial | Journal of the American Society of Hypertension | 2012 | 212 |
6 | Blood pressure effects of sodium–glucose co-transport 2 (SGLT2) inhibitors | Journal of the American Society of Hypertension | 2014 | 201 |
7 | A content analysis of smartphone–based applications for hypertension management | Journal of the American Society of Hypertension | 2015 | 178 |
8 | Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells | Journal of the American Society of Hypertension | 2012 | 175 |
9 | Combination therapy in hypertension | Journal of the American Society of Hypertension | 2010 | 173 |
10 | Oscillometric blood pressure: a review for clinicians | Journal of the American Society of Hypertension | 2014 | 159 |
11 | Global prevalence of hypertension among people living with HIV: a systematic review and meta-analysis | Journal of the American Society of Hypertension | 2017 | 159 |
12 | Combination therapy in hypertension | Journal of the American Society of Hypertension | 2010 | 156 |
13 | Vascular smooth muscle cell signaling mechanisms for contraction to angiotensin II and endothelin-1 | Journal of the American Society of Hypertension | 2009 | 150 |
14 | Are video sharing Web sites a useful source of information on hypertension? | Journal of the American Society of Hypertension | 2014 | 148 |
15 | Vascular toxicities with VEGF inhibitor therapies–focus on hypertension and arterial thrombotic events | Journal of the American Society of Hypertension | 2018 | 141 |
16 | Visit-to-visit blood pressure variations: New independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease | Journal of the American Society of Hypertension | 2011 | 138 |
17 | Evidence for a critical role of the sympathetic nervous system in hypertension | Journal of the American Society of Hypertension | 2016 | 138 |
18 | Worldwide prevalence of hypertension exceeds 1.3 billion | Journal of the American Society of Hypertension | 2016 | 131 |
19 | Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases | Journal of the American Society of Hypertension | 2008 | 130 |
20 | Hypertension in pregnancy | Journal of the American Society of Hypertension | 2010 | 126 |
21 | 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary | Journal of the American Society of Hypertension | 2018 | 126 |
22 | ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly | Journal of the American Society of Hypertension | 2011 | 125 |
23 | Hypertension in pregnancy | Journal of the American Society of Hypertension | 2008 | 117 |
24 | Occupational stress and hypertension | Journal of the American Society of Hypertension | 2012 | 117 |
25 | Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality | Journal of the American Society of Hypertension | 2014 | 113 |
26 | Effectiveness of the selective aldosterone blocker, eplerenone, in patients with resistant hypertension | Journal of the American Society of Hypertension | 2008 | 110 |
27 | Orthostatic hypotension: a common, serious and underrecognized problem in hospitalized patients | Journal of the American Society of Hypertension | 2012 | 106 |
28 | Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings | Journal of the American Society of Hypertension | 2014 | 103 |
29 | MicroRNAs in pulmonary arterial hypertension: pathogenesis, diagnosis and treatment | Journal of the American Society of Hypertension | 2015 | 103 |
30 | Sleep, insomnia, and hypertension: current findings and future directions | Journal of the American Society of Hypertension | 2017 | 98 |
31 | Oxidative stress and hypertension | Journal of the American Society of Hypertension | 2007 | 97 |
32 | MicroRNA-9 and microRNA-126 expression levels in patients with essential hypertension: potential markers of target-organ damage | Journal of the American Society of Hypertension | 2014 | 96 |
33 | Adherence and persistence with taking medication to control high blood pressure | Journal of the American Society of Hypertension | 2011 | 95 |
34 | When and how to use self (home) and ambulatory blood pressure monitoring | Journal of the American Society of Hypertension | 2008 | 92 |
35 | Barriers to conducting ambulatory and home blood pressure monitoring during hypertension screening in the United States | Journal of the American Society of Hypertension | 2017 | 92 |
36 | Sarcopenic obesity as an independent risk factor of hypertension | Journal of the American Society of Hypertension | 2013 | 91 |
37 | Antihypertensive efficacy, safety, and tolerability of the oral direct renin inhibitor aliskiren in patients with hypertension: a pooled analysis | Journal of the American Society of Hypertension | 2007 | 86 |
38 | A review of endothelial dysfunction in diabetes: a focus on the contribution of a dysfunctional eNOS | Journal of the American Society of Hypertension | 2010 | 84 |
39 | Efficacy and safety of the selective 11β-HSD-1 inhibitors MK-0736 and MK-0916 in overweight and obese patients with hypertension | Journal of the American Society of Hypertension | 2011 | 83 |
40 | Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR | Journal of the American Society of Hypertension | 2011 | 83 |
41 | SGLT2 inhibitors: their potential reduction in blood pressure | Journal of the American Society of Hypertension | 2015 | 82 |
42 | Evaluation and treatment of orthostatic hypotension | Journal of the American Society of Hypertension | 2013 | 81 |
43 | Potassium homeostasis in health and disease: A scientific workshop cosponsored by the National Kidney Foundation and the American Society of Hypertension | Journal of the American Society of Hypertension | 2017 | 81 |
44 | Exercise and other nonpharmacological strategies to reduce blood pressure in older adults: a systematic review and meta-analysis | Journal of the American Society of Hypertension | 2018 | 79 |
45 | New insights into the true nature of the obesity paradox and the lower cardiovascular risk | Journal of the American Society of Hypertension | 2013 | 78 |
46 | Potential benefits of exercise on blood pressure and vascular function | Journal of the American Society of Hypertension | 2013 | 76 |
47 | Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness | Journal of the American Society of Hypertension | 2014 | 75 |
48 | Active ambulatory care management supported by short message services and mobile phone technology in patients with arterial hypertension | Journal of the American Society of Hypertension | 2012 | 74 |
49 | The Mosaic Theory revisited: common molecular mechanisms coordinating diverse organ and cellular events in hypertension | Journal of the American Society of Hypertension | 2013 | 74 |
50 | Comparison of Morisky Medication Adherence Scale with therapeutic drug monitoring in apparent treatment–resistant hypertension | Journal of the American Society of Hypertension | 2015 | 74 |